vs
瑞思迈（RMD）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是ROKU, INC的1.0倍（$1.4B vs $1.4B），瑞思迈净利率更高（27.6% vs 5.8%，领先21.8%），ROKU, INC同比增速更快（16.1% vs 11.0%），瑞思迈自由现金流更多（$311.2M vs $106.6M），过去两年ROKU, INC的营收复合增速更高（25.8% vs 9.0%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
RMD vs ROKU — 直观对比
营收规模更大
RMD
是对方的1.0倍
$1.4B
营收增速更快
ROKU
高出5.2%
11.0%
净利率更高
RMD
高出21.8%
5.8%
自由现金流更多
RMD
多$204.6M
$106.6M
两年增速更快
ROKU
近两年复合增速
9.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $392.6M | $80.5M |
| 毛利率 | 61.8% | 43.5% |
| 营业利润率 | 34.6% | 4.7% |
| 净利率 | 27.6% | 5.8% |
| 营收同比 | 11.0% | 16.1% |
| 净利润同比 | 13.9% | 326.4% |
| 每股收益（稀释后） | $2.68 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDROKU
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $968.2M | ||
| Q1 24 | $1.2B | $881.5M |
净利润RMDROKU
| Q4 25 | $392.6M | $80.5M | ||
| Q3 25 | $348.5M | $24.8M | ||
| Q2 25 | $379.7M | $10.5M | ||
| Q1 25 | $365.0M | $-27.4M | ||
| Q4 24 | $344.6M | $-35.5M | ||
| Q3 24 | $311.4M | $-9.0M | ||
| Q2 24 | $292.2M | $-34.0M | ||
| Q1 24 | $300.5M | $-50.9M |
毛利率RMDROKU
| Q4 25 | 61.8% | 43.5% | ||
| Q3 25 | 61.5% | 43.4% | ||
| Q2 25 | 60.8% | 44.8% | ||
| Q1 25 | 59.3% | 43.6% | ||
| Q4 24 | 58.6% | 42.7% | ||
| Q3 24 | 58.6% | 45.2% | ||
| Q2 24 | 58.5% | 43.9% | ||
| Q1 24 | 57.9% | 44.1% |
营业利润率RMDROKU
| Q4 25 | 34.6% | 4.7% | ||
| Q3 25 | 33.4% | 0.8% | ||
| Q2 25 | 33.7% | -2.1% | ||
| Q1 25 | 33.0% | -5.7% | ||
| Q4 24 | 32.5% | -3.3% | ||
| Q3 24 | 31.6% | -3.4% | ||
| Q2 24 | 31.2% | -7.4% | ||
| Q1 24 | 31.3% | -8.2% |
净利率RMDROKU
| Q4 25 | 27.6% | 5.8% | ||
| Q3 25 | 26.1% | 2.0% | ||
| Q2 25 | 28.2% | 0.9% | ||
| Q1 25 | 28.3% | -2.7% | ||
| Q4 24 | 26.9% | -3.0% | ||
| Q3 24 | 25.4% | -0.9% | ||
| Q2 24 | 23.9% | -3.5% | ||
| Q1 24 | 25.1% | -5.8% |
每股收益（稀释后）RMDROKU
| Q4 25 | $2.68 | $0.55 | ||
| Q3 25 | $2.37 | $0.16 | ||
| Q2 25 | $2.58 | $0.07 | ||
| Q1 25 | $2.48 | $-0.19 | ||
| Q4 24 | $2.34 | $-0.24 | ||
| Q3 24 | $2.11 | $-0.06 | ||
| Q2 24 | $1.97 | $-0.24 | ||
| Q1 24 | $2.04 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $2.3B |
| 总债务越低越好 | $403.9M | — |
| 股东权益账面价值 | $6.3B | $2.7B |
| 总资产 | $8.5B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.06× | — |
8季度趋势，按日历期对齐
现金及短期投资RMDROKU
| Q4 25 | $1.4B | $2.3B | ||
| Q3 25 | $1.4B | $2.3B | ||
| Q2 25 | $1.2B | $2.3B | ||
| Q1 25 | $932.7M | $2.3B | ||
| Q4 24 | $521.9M | $2.2B | ||
| Q3 24 | $426.4M | $2.1B | ||
| Q2 24 | $238.4M | $2.1B | ||
| Q1 24 | $237.9M | $2.1B |
总债务RMDROKU
| Q4 25 | $403.9M | — | ||
| Q3 25 | $408.7M | — | ||
| Q2 25 | $658.4M | — | ||
| Q1 25 | $663.1M | — | ||
| Q4 24 | $662.9M | — | ||
| Q3 24 | $667.6M | — | ||
| Q2 24 | $697.3M | — | ||
| Q1 24 | $997.0M | — |
股东权益RMDROKU
| Q4 25 | $6.3B | $2.7B | ||
| Q3 25 | $6.1B | $2.6B | ||
| Q2 25 | $6.0B | $2.6B | ||
| Q1 25 | $5.5B | $2.5B | ||
| Q4 24 | $5.3B | $2.5B | ||
| Q3 24 | $5.2B | $2.5B | ||
| Q2 24 | $4.9B | $2.4B | ||
| Q1 24 | $4.6B | $2.4B |
总资产RMDROKU
| Q4 25 | $8.5B | $4.4B | ||
| Q3 25 | $8.3B | $4.4B | ||
| Q2 25 | $8.2B | $4.3B | ||
| Q1 25 | $7.6B | $4.2B | ||
| Q4 24 | $7.1B | $4.3B | ||
| Q3 24 | $7.2B | $4.3B | ||
| Q2 24 | $6.9B | $4.1B | ||
| Q1 24 | $6.8B | $4.2B |
负债/权益比RMDROKU
| Q4 25 | 0.06× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $339.7M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $311.2M | $106.6M |
| 自由现金流率自由现金流/营收 | 21.9% | 7.6% |
| 资本支出强度资本支出/营收 | 2.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 0.87× | 1.34× |
| 过去12个月自由现金流最近4个季度 | $1.8B | $478.4M |
8季度趋势，按日历期对齐
经营现金流RMDROKU
| Q4 25 | $339.7M | $107.7M | ||
| Q3 25 | $457.3M | $127.6M | ||
| Q2 25 | $538.8M | $109.7M | ||
| Q1 25 | $578.7M | $138.7M | ||
| Q4 24 | $308.6M | $79.3M | ||
| Q3 24 | $325.5M | $68.7M | ||
| Q2 24 | $440.1M | $23.4M | ||
| Q1 24 | $402.0M | $46.7M |
自由现金流RMDROKU
| Q4 25 | $311.2M | $106.6M | ||
| Q3 25 | $414.4M | $126.5M | ||
| Q2 25 | $508.2M | $108.6M | ||
| Q1 25 | $557.9M | $136.8M | ||
| Q4 24 | $288.0M | $76.8M | ||
| Q3 24 | $307.7M | $67.6M | ||
| Q2 24 | $415.2M | $22.5M | ||
| Q1 24 | $380.8M | $46.0M |
自由现金流率RMDROKU
| Q4 25 | 21.9% | 7.6% | ||
| Q3 25 | 31.0% | 10.4% | ||
| Q2 25 | 37.7% | 9.8% | ||
| Q1 25 | 43.2% | 13.4% | ||
| Q4 24 | 22.5% | 6.4% | ||
| Q3 24 | 25.1% | 6.4% | ||
| Q2 24 | 33.9% | 2.3% | ||
| Q1 24 | 31.8% | 5.2% |
资本支出强度RMDROKU
| Q4 25 | 2.0% | 0.1% | ||
| Q3 25 | 3.2% | 0.1% | ||
| Q2 25 | 2.3% | 0.1% | ||
| Q1 25 | 1.6% | 0.2% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 2.0% | 0.1% | ||
| Q1 24 | 1.8% | 0.1% |
现金转化率RMDROKU
| Q4 25 | 0.87× | 1.34× | ||
| Q3 25 | 1.31× | 5.14× | ||
| Q2 25 | 1.42× | 10.45× | ||
| Q1 25 | 1.59× | — | ||
| Q4 24 | 0.90× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
